Diabetes :: Joslin?s Latino Diabetes Initiative Launches Its First Audio-Novella

Rosa?s Story, an audio-novella from the Joslin Diabetes Center Latino Diabetes Initiative, uses the art of storytelling to educate listeners about the challenges of diabetes faced by the Hispanic/Latino population. The first-person accounts of a fictitious Latino woman with type 2 diabetes, and a teenager with pre-diabetes, are told in the new educational package. Designed for Spanish-speaking Latinos with diabetes and their families, the three-CD set is being launched on Nov. 14, World Diabetes Day, a day set aside by the International Diabetes Federation (IDF) and the World Health Organization to increase public awareness of the global diabetes epidemic.

Teen girls make better health choices with intervention program

For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.

Teen girls make better health choices with intervention program

For two consecutive years, researchers examined measures of cardiovascular fitness and self-esteem in sophomore girls attending Trenton Central High School and found students are making better health choices with an intervention program. Low Density Lipoprotein levels — the unhealthy cholesterol — also decreased significantly. WHF Teen Esteem is a gender-specific approach to teen girls’ health and wellness and is meant to be a replacement for traditional gymnastics and health classes.

Childhood Acid Reflux Disease Poses Challenges for Many Families, National Survey Reveals

Almost everyone suffers from occasional heartburn, even kids. However, if symptoms are persistent and occur two or more days a week, it could signify a condition known as acid reflux disease, commonly known as GERD, which affects roughly two to eight percent of children in the United States. A recent online survey conducted by StrategyOne found that GERD can have a significant impact on kids? lifestyles, and nearly four in ten (38%) parents wished they had more resources about GERD in children.

Genes Offer Researchers a ‘Crystal Ball’ to Help Them Prevent, Diagnose, and Treat Cancer

The science of cancer prevention has advanced to the point where researchers now say they can detect ?cancer genes? in the breath of smokers, and can test the presence of two proteins in men they say will predict development of prostate cancer a decade in advance. All of these novel findings need much more examination, of course, but scientists at the American Association for Cancer Research?s Frontiers in Cancer Prevention Research meeting, say these examples illustrate how it is becoming increasingly possible to use genes and their protein products to help predict and diagnose cancer, as well as choose therapy that offers the most potential for a good result. These researchers will also discuss a test that can pick out patients who have pancreatic cancer – an advance that offers hope the disease can be treated at earlier stages than it is now – and how several unique genes can predict which prostate cancer or lung cancer patients will develop aggressive tumors that need additional treatment. Cancer is a disease of genes, they say, so genes can be employed as a crystal ball to thwart the disease.

Rheumatoid Arthritis :: ORENCIA, abatacept demonstrate continued efficacy in adults with rheumatoid arthritis

Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA? (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. The data also demonstrate that ORENCIA provided clinically meaningful improvements in multiple aspects of health-related quality of life and physical function, sustained improvements in pain and had a consistent safety and tolerability profile through two years of treatment. These data will be presented at the upcoming 2006 American College of Rheumatology (ACR) Annual Scientific Meeting.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack